159 related articles for article (PubMed ID: 24642358)
1. Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease.
Al Kindi H; Hafiane A; You Z; Albanese I; Pilote L; Genest J; Schwertani A
Peptides; 2014 May; 55():151-7. PubMed ID: 24642358
[TBL] [Abstract][Full Text] [Related]
2. Urotensin-II levels in acute coronary syndromes.
Joyal D; Huynh T; Aiyar N; Guida B; Douglas S; Giaid A
Int J Cardiol; 2006 Mar; 108(1):31-5. PubMed ID: 16516696
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Changes in Plasma Urotensin II and Its Correlation With Plaque Stability.
Yin CL; Liu X; Wang HX; Yan MC; Guo LJ; Li GN; Xia JG; Yuan HH; Yin Y
J Cardiovasc Pharmacol; 2021 Jul; 78(1):e147-e155. PubMed ID: 34173803
[TBL] [Abstract][Full Text] [Related]
5. The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease.
Heringlake M; Kox T; Uzun O; Will B; Bahlmann L; Klaus S; Eleftheriadis S; Armbruster FP; Franz N; Kraatz E
Regul Pept; 2004 Sep; 121(1-3):129-36. PubMed ID: 15256283
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma urotensin II levels in patients with diabetes mellitus.
Totsune K; Takahashi K; Arihara Z; Sone M; Ito S; Murakami O
Clin Sci (Lond); 2003 Jan; 104(1):1-5. PubMed ID: 12519081
[TBL] [Abstract][Full Text] [Related]
7. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury.
Prosser HC; Forster ME; Richards AM; Pemberton CJ
Peptides; 2008 May; 29(5):770-7. PubMed ID: 17900760
[TBL] [Abstract][Full Text] [Related]
8. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I
J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417
[TBL] [Abstract][Full Text] [Related]
9. Urotensin II immunoreactivity in the human circulation: evidence for widespread tissue release.
Chen YH; Yandle TG; Richards AM; Palmer SC
Clin Chem; 2009 Nov; 55(11):2040-8. PubMed ID: 19797715
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia.
Ban Y; Watanabe T; Suguro T; Matsuyama TA; Iso Y; Sakai T; Sato R; Idei T; Nakano Y; Ota H; Miyazaki A; Kato N; Hirano T; Ban Y; Kobayashi Y
J Atheroscler Thromb; 2009 Jun; 16(3):179-87. PubMed ID: 19638714
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of native and non-native urotensin II and urotensin II-related peptide on rat and salmon hearts.
Prosser HC; Leprince J; Vaudry H; Richards AM; Forster ME; Pemberton CJ
Peptides; 2006 Dec; 27(12):3261-8. PubMed ID: 17097764
[TBL] [Abstract][Full Text] [Related]
12. Is plasma urotensin II concentration an indicator of myocardial damage in patients with acute coronary syndrome?
Babińska M; Holecki M; Prochaczek F; Owczarek A; Kokocińska D; Chudek J; Więcek A
Arch Med Sci; 2012 Jul; 8(3):449-54. PubMed ID: 22851999
[TBL] [Abstract][Full Text] [Related]
13. The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification.
Albanese I; Daskalopoulou SS; Yu B; You Z; Genest J; Alsheikh-Ali A; Schwertani AG
Front Pharmacol; 2016; 7():149. PubMed ID: 27375483
[TBL] [Abstract][Full Text] [Related]
14. [Study on the effect of adrenomedulin and urotensin-II on pulmonary hypertension of patients with congenital heart disease].
Wang T; Li SX; Zhang XQ; Gu XH; Song Y; Zhang G; Wu SM
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(38):2691-5. PubMed ID: 16324296
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
[TBL] [Abstract][Full Text] [Related]
16. The relationship of urotensin II with insulin resistance and hs-CRP in patients having PCOS.
Yilmaz Ö; Calan O; Kume T; Calan M
Gynecol Endocrinol; 2013 Nov; 29(11):970-3. PubMed ID: 23981122
[TBL] [Abstract][Full Text] [Related]
17. Neurokinin B and urotensin II levels in pre-eclampsia.
Liu Y; Li Y; Xu X; Chen X; Chen H
J Matern Fetal Neonatal Med; 2010 Aug; 23(8):869-73. PubMed ID: 20017703
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy.
Langham RG; Kelly DJ; Gow RM; Zhang Y; Dowling JK; Thomson NM; Gilbert RE
Am J Kidney Dis; 2004 Nov; 44(5):826-31. PubMed ID: 15492948
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
[TBL] [Abstract][Full Text] [Related]
20. Plasma urotensin II and neurokinin B levels in acute myocardial infarction and stable coronary artery disease.
Akkoyun DÇ; Akyüz A; Alpsoy Ş; Gürel A; Güler N; Değirmenci H; Gürkan Ü
Anatol J Cardiol; 2015 Aug; 15(8):628-33. PubMed ID: 25550175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
